103 related articles for article (PubMed ID: 17304472)
1. Production and biological evaluation of [18F]-6-thia-14-fluoro-heptadecanoic acid.
Jalilian AR; Akhlaghi M; Mirzaii M; Karimian AR
Nucl Med Rev Cent East Eur; 2006; 9(2):108-13. PubMed ID: 17304472
[TBL] [Abstract][Full Text] [Related]
2. 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid as a tracer of free fatty acid uptake and oxidation in myocardium and skeletal muscle.
Takala TO; Nuutila P; Pulkki K; Oikonen V; Grönroos T; Savunen T; Vähäsilta T; Luotolahti M; Kallajoki M; Bergman J; Forsback S; Knuuti J
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1617-22. PubMed ID: 12458396
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of trans-9-18F-fluoro-3,4-Methyleneheptadecanoic acid as a PET tracer for myocardial fatty acid imaging.
Shoup TM; Elmaleh DR; Bonab AA; Fischman AJ
J Nucl Med; 2005 Feb; 46(2):297-304. PubMed ID: 15695790
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and preliminary evaluation of (18)F-labeled 4-thia palmitate as a PET tracer of myocardial fatty acid oxidation.
DeGrado TR; Wang S; Holden JE; Nickles RJ; Taylor M; Stone CK
Nucl Med Biol; 2000 Apr; 27(3):221-31. PubMed ID: 10832078
[TBL] [Abstract][Full Text] [Related]
5. Myocardial uptake of the fatty acid analog 14-fluorine-18-fluoro-6-thia-heptadecanoic acid in comparison to beta-oxidation rates by tritiated palmitate.
Stone CK; Pooley RA; DeGrado TR; Renstrom B; Nickles RJ; Nellis SH; Liedtke AJ; Holden JE
J Nucl Med; 1998 Oct; 39(10):1690-6. PubMed ID: 9776270
[TBL] [Abstract][Full Text] [Related]
6. Free fatty acid uptake in the myocardium and skeletal muscle using fluorine-18-fluoro-6-thia-heptadecanoic acid.
Mäki MT; Haaparanta M; Nuutila P; Oikonen V; Luotolahti M; Eskola O; Knuuti JM
J Nucl Med; 1998 Aug; 39(8):1320-7. PubMed ID: 9708500
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and preliminary evaluation of 18-(18)F-fluoro-4-thia-oleate as a PET probe of fatty acid oxidation.
DeGrado TR; Bhattacharyya F; Pandey MK; Belanger AP; Wang S
J Nucl Med; 2010 Aug; 51(8):1310-7. PubMed ID: 20660391
[TBL] [Abstract][Full Text] [Related]
8. Automated production of [
Savisto N; Viljanen T; Kokkomäki E; Bergman J; Solin O
J Labelled Comp Radiopharm; 2018 Feb; 61(2):84-93. PubMed ID: 29205456
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
Taylor M; Wallhaus TR; Degrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK
J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981
[TBL] [Abstract][Full Text] [Related]
10. 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid (FTHA): evaluation in mouse of a new probe of myocardial utilization of long chain fatty acids.
DeGrado TR; Coenen HH; Stocklin G
J Nucl Med; 1991 Oct; 32(10):1888-96. PubMed ID: 1919727
[TBL] [Abstract][Full Text] [Related]
11. Radiation induced oxidation of [
Pandey MK; Jacobson MS; Groth EK; Tran NG; Lowe VJ; DeGrado TR
Nucl Med Biol; 2020; 80-81():13-23. PubMed ID: 31759313
[TBL] [Abstract][Full Text] [Related]
12. 17-[4-(2-[18F]fluoroethyl)-1H-1,2,3-triazol-1-yl]-6-thia-heptadecanoic acid: a potential radiotracer for the evaluation of myocardial fatty acid metabolism.
Kim DH; Choe YS; Choi JY; Choi Y; Lee KH; Kim BT
Bioconjug Chem; 2009 Jun; 20(6):1139-45. PubMed ID: 19530707
[TBL] [Abstract][Full Text] [Related]
13. Validation of 18F-fluoro-4-thia-palmitate as a PET probe for myocardial fatty acid oxidation: effects of hypoxia and composition of exogenous fatty acids.
DeGrado TR; Kitapci MT; Wang S; Ying J; Lopaschuk GD
J Nucl Med; 2006 Jan; 47(1):173-81. PubMed ID: 16391202
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of 14(R,S)-fluorine-18-fluoro-6-thia-heptadecanoic acid in normal human hearts at rest, during exercise and after dipyridamole injection.
Ebert A; Herzog H; Stöcklin GL; Henrich MM; DeGrado TR; Coenen HH; Feinendegen LE
J Nucl Med; 1994 Jan; 35(1):51-6. PubMed ID: 8271060
[TBL] [Abstract][Full Text] [Related]
15. Liver uptake of free fatty acids in vivo in humans as determined with 14( R, S)-[18F]fluoro-6-thia-heptadecanoic acid and PET.
Iozzo P; Turpeinen AK; Takala T; Oikonen V; Solin O; Ferrannini E; Nuutila P; Knuuti J
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1160-4. PubMed ID: 12811532
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of 15-(4-(2-[¹⁸F]Fluoroethoxy)phenyl)pentadecanoic acid: a potential PET tracer for studying myocardial fatty acid metabolism.
Tu Z; Li S; Sharp TL; Herrero P; Dence CS; Gropler RJ; Mach RH
Bioconjug Chem; 2010 Dec; 21(12):2313-9. PubMed ID: 21070001
[TBL] [Abstract][Full Text] [Related]
17. A Fully Automated Synthesis of 14-(
Ustsinau U; Nics L; Hacker M; Philippe C
Pharmaceuticals (Basel); 2024 Feb; 17(3):. PubMed ID: 38543104
[TBL] [Abstract][Full Text] [Related]
18. Comparison of fatty acid tracers FTHA and BMIPP during myocardial ischemia and hypoxia.
Renstrom B; Rommelfanger S; Stone CK; DeGrado TR; Carlson KJ; Scarbrough E; Nickles RJ; Liedtke AJ; Holden JE
J Nucl Med; 1998 Oct; 39(10):1684-9. PubMed ID: 9776269
[TBL] [Abstract][Full Text] [Related]
19. The effect of insulin on the intracellular distribution of 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid in rats.
Ci X; Frisch F; Lavoie F; Germain P; Lecomte R; van Lier JE; Bénard F; Carpentier AC
Mol Imaging Biol; 2006; 8(4):237-44. PubMed ID: 16791750
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution of the fatty acid analogue 18F-FTHA: plasma and tissue partitioning between lipid pools during fasting and hyperinsulinemia.
Guiducci L; Grönroos T; Järvisalo MJ; Kiss J; Viljanen A; Naum AG; Viljanen T; Savunen T; Knuuti J; Ferrannini E; Salvadori PA; Nuutila P; Iozzo P
J Nucl Med; 2007 Mar; 48(3):455-62. PubMed ID: 17332624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
